Talzenna
Active substance: talazoparib tosylate
CAPSULE, LIQUID FILLED · TALAZOPARIB TOSYLATE 1 mg/1
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TALAZOPARIB TOSYLATE · 1 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3e24-7822-9b7c-bf048157614f,01a1208c-3f76-769a-8e90-1c86d7ec0170,01a1208c-4061-7bed-882c-f613f4dcd442,01a1208c-4254-7589-b4bb-275bc3d9e888,01a1208c-e218-7a19-b689-28b3b3aa54e8;count=12 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0069-0757
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0069-0757 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-0757 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-0757 · Verified 2026-10-09 · open in source